Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Current Colorectal Cancer Reports

Issue 3/2013

Content (10 Articles)

Therapeutic Approaches to Metastatic Colorectal Cancers (E Díaz-Rubio, Section Editor)

Treatment Strategy for Elderly Patients with Metastatic Colorectal Cancer: A Review of the Systemic Chemotherapy Options

Yong Sang Hong, Jee Hyun Kim, Tae Won Kim

Therapeutic Approaches to Metastatic Colorectal Cancers (E Díaz-Rubio, Section Editor)

Optimum Duration of Metastatic Colorectal Cancer Treatment

Alexander Stein, Hans-Joachim Schmoll

Therapeutic Approaches to Metastatic Colorectal Cancers (E Díaz-Rubio, Section Editor)

The Continuum of Care in Chemotherapy Approach to Metastatic Colorectal Cancer

Jenia Jenab-Wolcott, Bruce Giantonio

Therapeutic Approaches to Metastatic Colorectal Cancers (E Díaz-Rubio, Section Editor)

Role of Chemotherapy in Peritoneal Carcinomatosis in Metastatic Colorectal Cancer

Jan Franko, Charles D. Goldman, Kiran K. Turaga

Therapeutic Approaches to Metastatic Colorectal Cancer (E Díaz-Rubio, Section Editor)

Management of Toxicity Induced by Anti-EGFR Therapy in Metastatic Colorectal Cancer

Christian Rolfo, Giuseppe Bronte, Francesco Passiglia, Konstantinos Papadimitriou, Antonio Russo, Marc Peeters

Open Access Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status

Thierry André, Timothy Iveson, Roberto Labianca, Jeffrey A. Meyerhardt, Ioannis Souglakos, Takayuki Yoshino, James Paul, Alberto Sobrero, Julien Taieb, Anthony F. Shields, Atsushi Ohtsu, Axel Grothey, Daniel J. Sargent

Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

Functions and Clinical Implications of Autocrine VEGF Signaling in Colorectal Cancer

Annette K. Larsen, Aimery de Gramont, Virginie Poindessous, Anaïs Bouygues, Mériam Ayadi, Paul Mésange

Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

Animal Models to Test Adjuvant Treatment: An Experimental Model of Colon Cancer

Selma Becherirat, Fatemeh Valamanesh, Clarisse Eveno, Julie Sedbon, Thierry Andre, Marc Pocard

Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

The Role of Adjuvant Therapy in the Elderly

Christina Wu, Richard M. Goldberg

Adjuvant Therapy for Colon Cancers (AB Benson III and A de Gramont, Section Editors)

Clinical Reasons for Initiation of Adjuvant Phase III Trials on Colon Cancer

Aimery de Gramont, Benoist Chibaudel, Franck Bonnetain, Sarah Dumont, Annette K. Larsen, Thierry André

Jun 13
Issue: 2/2013
Dec 13
Issue: 4/2013

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits